NXTC•benzinga•
NextCure And LigaChemBio Announces They Will Present Trial In Progress Poster For LNCB74, A B7-H4 Targeted Antibody-Drug Conjugate, As Monotherapy In Participants With Advanced Solid Tumors At American Society of Clinical Oncology 2025
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 29, 2025 by benzinga